← Back to All Filings

Sensus Healthcare President Buys $8.5k in SRTS Stock

Low SignificanceNovember 13, 2025 at 9:34:02 AM EST

Sensus Healthcare, Inc.

$SRTS4/ACIK: 0001494891

Subscribe to track SRTS

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Sensus Healthcare President Buys $8.5k in SRTS Stock

Company: Sensus Healthcare, Inc. (SRTS) Form: 4/A | Filed: 2025-11-13 Significance: Low

Insider: Sardano Michael Title: PRESIDENT AND GENERAL COUNSEL | Relationship: Director, Officer

Transaction: • Type: Buy • Shares: 2,000 • Price: ~$4.26 (avg) • Value: $8,523 • Owned After: 118,839

Key Insight: A low-value open market purchase by a key executive, representing a minor addition to his existing holdings. The transaction size is negligible compared to the company's market cap.

Market Context: The purchase consists of multiple small transactions, both direct and indirect (via spouse), indicating routine accumulation rather than a significant strategic move.

Comprehensive Analysis

SEC Filing Analysis: Sensus Healthcare, Inc. (SRTS)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: A key executive made a small, routine open-market purchase of company stock, totaling approximately $8,500.
  • Market Impact: Neutral. The transaction is too small to be considered a significant market signal.

Company Information

FieldValue
CompanySensus Healthcare, Inc.
Ticker SymbolSRTS
CIK0001494891
IndustrySurgical & Medical Instruments & Apparatus

Insider Information

FieldValue
NameSardano Michael
CIK0001720602
Title/PositionPRESIDENT AND GENERAL COUNSEL
RelationshipDirector, Officer

Transaction Details

FieldValue
Form Type4/A
Transaction Date2025-11-11
Transaction CodeP (Open Market Purchase)
Security TypeCommon Stock
Shares Involved2,000
Average Price Per Share$4.26
Total Value$8,522.98
Shares Owned After118,839
Ownership TypeMix of Direct and Indirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$8,522.98
% of Market Cap0.012%
Shares Transacted2,000
% of Shares Outstanding0.012%
Post-Transaction Ownership118,839 shares (0.72% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: Sensus Healthcare is a micro-cap company with a market capitalization of approximately $70 million. The transaction value of ~$8.5k is immaterial in this context.
  • Ownership Concentration: The insider's post-transaction ownership of 0.72% is a modest stake. This purchase slightly increases his holdings but does not materially change his ownership percentage.
  • Transaction Significance: Based on the transaction's value as a percentage of market cap (0.012%) and shares outstanding (0.012%), the significance is low. It does not meet the thresholds for moderate or high significance.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: While insider buying is generally a positive sign, the transaction's value is too small to imply any new, non-public information or to have a tangible impact on the stock.

Volume & Sentiment

  • Expected Volume Impact: Negligible. The transaction size is a tiny fraction of typical daily trading volume.
  • Sentiment Indicator: Neutral. The purchase is too small to be considered a bullish signal.

Additional Context

Transaction Notes

  • This Form 4/A is an amendment to a previous filing. The filing reports three separate purchase transactions on the same day at slightly different prices.
  • The purchases were a mix of direct ownership (1,000 shares) and indirect ownership via a spouse (1,000 shares).
Topics:#SECFiling#InsiderTrading#SRTS#SensusHealthcare#Form4#InsiderBuy#StockMarket#Investing#MarketAnalysis

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.